Other amylin-based molecules which are in early stage clinical trials include long-acting amylin agonists and a dual amylin and calcitonin RA (Table 1)
Yes, most users can continue tirzepatide despite muscle pain by implementing strategies to address the underlying causes
From a public health perspective, these disparities have far-reaching implications
This may reflect the absence of effect of DPP-4 on GE or the higher circulating concentrations of GLP-1 observed in PAM carriers may augment the effect of DPP-4i in prolonging the half-life of GLP-1, which may off set the expected GLP-1 resistance [55]
Combined treatment with GLP1R and GIPR agonists may result in improved metabolic and antidiabetic responses, with GIP indicating the potential of the agonist in CV health through its actions on lipid metabolism, insulin secretion, and cardioprotective properties 29
In essence, GLP-1 Injections help balance blood sugar levels and curb excessive cravings, guiding the body toward healthier habits